| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.042 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.036 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |